Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CABOTEGRAVIR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04692077
What this trial is testing

Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 9
Not applicableNot Yet RecruitingNCT07390409
What this trial is testing

ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.

Who this might be right for
HIV
Desmond Tutu HIV Foundation 3,700
Not applicableStudy completedNCT06159894
What this trial is testing

Implementation of Long-acting Cabotegravir + Rilpivirine Administration Out of "HIV Units".

Who this might be right for
HIV Infections
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 90
Post-approval studies (Phase 4)Active Not RecruitingNCT05986084
What this trial is testing

Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana

Who this might be right for
Pre-Exposure Prophylaxis (PrEP)Breast Feeding
Beth Israel Deaconess Medical Center 500
Not applicableLooking for participantsNCT07370649
What this trial is testing

Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study

Who this might be right for
Human Immunodeficiency Virus (HIV)-1 InfectionHIV-1 Subtype A6 InfectionHIV-1 Subtype B Infection+1 more
Pomeranian Medical University Szczecin 250
Early research (Phase 1)Active Not RecruitingNCT06970223
What this trial is testing

Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV

Who this might be right for
HIV Infections
ViiV Healthcare 65
Testing effectiveness (Phase 2)Study completedNCT03739996
What this trial is testing

Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Not applicableLooking for participantsNCT06424964
What this trial is testing

Use of Long-Acting Injectable Cabotegravir/Rilpivirine for the Treatment of HIV in Belgium

Who this might be right for
Human Immunodeficiency Virus
Belgian Research on AIDS and HIV Consortium 600
Post-approval studies (Phase 4)Looking for participantsNCT06485154
What this trial is testing

Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial

Who this might be right for
HIV Prevention
University of Witwatersrand, South Africa 100
Large-scale testing (Phase 3)Study completedNCT05917509
What this trial is testing

Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

Who this might be right for
HIV Infections
ViiV Healthcare 171
Early research (Phase 1)Study completedNCT04371380
What this trial is testing

Pharmacokinetic Study of Cabotegravir and Rilpivirine Long-acting Intramuscular Injections in Healthy Adult Participants

Who this might be right for
HIV Infections
ViiV Healthcare 15
Large-scale testing (Phase 3)Looking for participantsNCT05515770
What this trial is testing

The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir

Who this might be right for
HIV Infections
Evandro Chagas National Institute of Infectious Disease 1,200
Testing effectiveness (Phase 2)Active Not RecruitingNCT06741397
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M)

Who this might be right for
HIV Infections
ViiV Healthcare 229
Not applicableNot Yet RecruitingNCT07637942
What this trial is testing

Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

Who this might be right for
HIV -1 Infection
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 40
Post-approval studies (Phase 4)Study completedNCT05374525
What this trial is testing

A Study Evaluating Implementation Strategies for the Delivery of Cabotegravir in Low and High-Volume PrEP Site in the United States

Who this might be right for
HIV Infections
ViiV Healthcare 287
Large-scale testing (Phase 3)Active Not RecruitingNCT03164564
What this trial is testing

Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3,224
Not applicableStudy completedNCT05867212
What this trial is testing

Implementation and Delivery of Cabotegravir Long Acting Injection for PrEP in a Community Pharmacy Setting.

Who this might be right for
HIV Infections
Kelley-Ross & Associates, Inc. 50
Early research (Phase 1)Looking for participantsNCT05418868
What this trial is testing

Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants

Who this might be right for
HIV Infections
ViiV Healthcare 214
Post-approval studies (Phase 4)Study completedNCT05514509
What this trial is testing

A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories

Who this might be right for
HIV Infections
ViiV Healthcare 370
Large-scale testing (Phase 3)Looking for participantsNCT07650916
What this trial is testing

Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

Who this might be right for
HIV Infections
ViiV Healthcare 564
Next Page